Innocare Pharma Inc.

This phase 2 trial tested two different daily doses of the drug orelabrutinib in 40 people with mantle cell lymphoma, a rare blood cancer. The goal was to see which dose works better at shrinking tumors and controlling the disease. Participants included both newly diagnosed and r…

This early-phase trial tested the safety and tolerability of a new drug called ICP-332 in 24 healthy adults. Participants received either the drug or a placebo in multiple doses. The study is now complete and focused on monitoring side effects and changes in vital signs, ECG, and…